<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Jordan Pharma Compliance]]></title><description><![CDATA[JPC provides pharmaceutical consulting services that support client programs, including small-molecule to biologic products, from pre-clinical through post-marketing. We help companies work with Regulators to develop critical therapies and medicines quickly and safely, ensuring those programs do the most good for the most people.]]></description><link>https://www.jordan-pharma.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Mon, 21 Sep 2026 22:15:29 GMT</lastBuildDate><atom:link href="https://www.jordan-pharma.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[The SUPAC Comment Period Just Closed. That's Not the Same as "Nothing Happened."]]></title><description><![CDATA[What FDA's request for comments on the SUPAC guidances actually signals and why waiting for a final guidance is the expensive way to find out.]]></description><link>https://www.jordan-pharma.com/post/the-supac-comment-period-just-closed-that-s-not-the-same-as-nothing-happened</link><guid isPermaLink="false">6aab2181ae76983300750801</guid><pubDate>Wed, 05 Aug 2026 20:52:55 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d9998a_61bc21ecf3234c048ccf5c91263b2bf6~mv2.jpg/v1/fit/w_400,h_400,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>admin325725</dc:creator></item><item><title><![CDATA[Maybe Outsourcing Regulatory Judgement to the Robots is a Structural Risk]]></title><description><![CDATA[FDA’s recent deployment of agentic AI to support regulatory work raises important questions about institutional continuity, quality oversight, and long-term governance. There are broader implications as well.]]></description><link>https://www.jordan-pharma.com/post/outsourcing-to-robots</link><guid isPermaLink="false">6a8f1546b8cc6999fe070b49</guid><pubDate>Thu, 05 Mar 2026 17:33:10 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d9998a_ecc0ee3cb7ff441fae378444d22056b1~mv2.png/v1/fit/w_400,h_400,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>JPC Staff</dc:creator></item><item><title><![CDATA[Call to Action: Comment on M4Q(R2) ]]></title><description><![CDATA[The draft revision of ICH M4Q(R2) is now open for comment and adopted into the FDA’s docket, and you, yes you, must make some time to read and comment on it. ]]></description><link>https://www.jordan-pharma.com/post/comment-on-m4qr2</link><guid isPermaLink="false">6a8f153c6e0678c59a4f985a</guid><pubDate>Fri, 20 Feb 2026 17:33:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d9998a_bae57399c3644740b55ea2bbb60ef11d~mv2.png/v1/fit/w_400,h_400,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>JPC Staff</dc:creator></item><item><title><![CDATA[SEO Calisthenics: An Exercise in FDA Inspection Readiness Consulting ]]></title><description><![CDATA[This is a blog post about Search Engine Optimization (SEO).]]></description><link>https://www.jordan-pharma.com/post/seo-calisthenics-an-exercise-in-fda-inspection-readiness</link><guid isPermaLink="false">6a8f15476e0678c59a4f986f</guid><pubDate>Fri, 06 Feb 2026 17:33:11 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/d9998a_c58ba7a72bb54670a2adea4b8dfc924b~mv2.png/v1/fit/w_400,h_400,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>JPC Staff</dc:creator></item></channel></rss>